HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%- hyaluronic acid sodium salt 0.5% / tazarotene 0.1% cream 
Sincerus Florida, LLC

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

----------

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%

Directions for use

fd

SIncerus Florida, LLC. Adverse reactions

we

Active, inactive

xz

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1%. Cream 30 gm

sdf

HYALURONIC ACID SODIUM SALT 0.5% / TAZAROTENE 0.1% 
hyaluronic acid sodium salt 0.5% / tazarotene 0.1% cream
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-2094
Route of Administration TOPICAL
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
HYALURONATE SODIUM (UNII: YSE9PPT4TH) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONATE SODIUM 0.5 g  in 100 g
TAZAROTENE (UNII: 81BDR9Y8PS) (TAZAROTENE - UNII:81BDR9Y8PS) TAZAROTENE 0.1 g  in 100 g
Product Characteristics
Color white Score     
Shape Size
Flavor Imprint Code
Contains     
Packaging
# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:72934-2094-2 30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 05/07/2019
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
unapproved drug other 05/07/2019
Labeler - Sincerus Florida, LLC (080105003)
Establishment
Name Address ID/FEI Business Operations
Sincerus Florida, LLC 080105003 manufacture(72934-2094)

Revised: 5/2019
Document Id: 8838d911-0db3-f66e-e053-2995a90acb53
Set id: 8838d911-0db2-f66e-e053-2995a90acb53
Version: 1
Effective Time: 20190506
 
Sincerus Florida, LLC